Quantcast
Channel: Apothekersnieuws
Viewing all articles
Browse latest Browse all 1869

Merus starts Phase I/II clinical trial for MCLA-128

$
0
0
Merus B.V. in Utrecht, a leader in developing best-in-class bispecific antibody therapeutics to treat cancer patients, announced the initiation of a phase I/II clinical study of MCLA-128 for the treatment of solid tumors. MCLA-128 is an ADCC-enhanced, full-length IgG bispecific antibody that simultaneously targets the growth factor receptors HER2 and HER3. “Tumors with intrinsic or acquired resistance to… Read More »

Viewing all articles
Browse latest Browse all 1869

Trending Articles


Heeft iemand ervaring met Watchdeals.nl


Clash competition2 9ft pooltafel 1 jaar garantie


Thrustmaster ferrari gt


Iwan van der Zwaag


NL13 ABNA 0506 4173 44 TIKKIE


Te koop: Verlengde Stationsweg 40, Zuidlaren


Aan weerszijden steken afkanten voor de armsgaten


Te koop: Beulakerweg 69, Giethoorn


Programmering Icom marifoons VDES/ ATIS/ MMSI - door: omega


Te koop: Pleziervaart 13, Arnhem